Cost Issues Prevent a Quarter of Patients From Taking Insulin Print
Written by Becky McCall | Medscape   
Tuesday, 26 June 2018 17:08
6.23.18 - Orlando - Cost issues related to insulin use prevent a full quarter of patients with diabetes taking insulin as prescribed, and this is associated with poorer glycemic control, shows a new study. Low to middle income patients were worse off, the data indicate. Patients in the $25,000 to $99,000 income bracket were significantly more likely to underuse insulin because of cost barriers, Darby Herkert, BS, from Yale University, New Haven, Connecticut, reported here today at the American Diabetes Association (ADA) 2018 Scientific Sessions.  
Read More (Log in/complimentary subscription required.)

Last Updated on Tuesday, 26 June 2018 17:11